Funding Tracker
A tracked system dataset for our medical research coverage: what it measures, where the figures come from and when they were last checked.
Estuary Biotherapeutics Launches with $93M for ADPKD Gene Therapies
Estuary Biotherapeutics launched with $93 million in Series A funding to develop one-time gene therapies for autosomal dominant polycystic kidney...
Caribou Biosciences discontinues CAR-T therapies, cuts staff
Caribou Biosciences is halting development of two off-the-shelf CAR-T cancer therapies, including its Phase 3-ready candidate vispa-cel, and laying...
Moonwalk Biosciences pivots to RNAi obesity drugs with $70M
Moonwalk Biosciences has raised $70 million in Series B funding to advance a pipeline of RNA interference drugs for obesity.
AI Tool Prof. Valmed Speeds Up Rheumatology Diagnosis
A randomized trial found the AI system Prof. Valmed cut diagnosis time by more than half compared to physicians working alone.
Obesity Medicines Are Disruptive Innovation
A commentary in Nature Medicine argues that new anti-obesity drugs represent a disruptive innovation requiring health system adaptation.
FDA clears Juul's age-gated e-cigarette
The FDA has permitted Juul Labs to sell an updated version of its vaping device, the Juul2, which includes an optional age-verification system.
Nonprofit Health System Earns $1.1 Billion from Medical Billing Firm Stake
Bon Secours Mercy Health, a nonprofit health system, has earned significant revenue from its minority position in Ensemble Health Partners, a medical...